Showing results (211-220 of 784) with videos related to
Sort By:
Pageof 79
Plos One|September 13, 2022
Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in EthiopiaMuluwork Getahun, Henry M Blumberg, Gobena Ameni, et al.The Journal of Biological Chemistry|October 9, 2003
RasGRP1 represents a novel non-protein kinase C phorbol ester signaling pathway in mouse epidermal keratinocytesReshmi A Rambaratsingh, James C Stone, Peter M Blumberg, et al.The Lancet. Infectious Diseases|January 28, 2012
Surgical treatment of drug-resistant tuberculosisRussell R Kempker, Sergo Vashakidze, Nelly Solomonia, et al.American Journal of Respiratory and Critical Care Medicine|January 5, 1999
A tuberculin screening and isoniazid preventive therapy program in an inner-city populationN N Bock, B S Metzger, J R Tapia, et al.European Journal of Pharmacology|October 24, 1994
Visualization by [3H]resiniferatoxin autoradiography of capsaicin-sensitive neurons in the rat, pig and manA Szallasi, P M Blumberg, S Nilsson, et al.The Journal of Biological Chemistry|June 16, 1995
Low affinity binding of phorbol esters to protein kinase C and its recombinant cysteine-rich region in the absence of phospholipidsM G Kazanietz, J J Barchi, J G Omichinski, et al.The Journal of Biological Chemistry|September 16, 1994
Phosphorylation of the gamma chain of the high affinity receptor for immunoglobulin E by receptor-associated protein kinase C-deltaP Germano, J Gomez, M G Kazanietz, et al.Journal of Medicinal Chemistry|August 19, 2008
Conformationally constrained analogues of diacylglycerol. 30. An investigation of diacylglycerol-lactones containing heteroaryl groups reveals compounds with high selectivity for Ras guanyl nucleotide-releasing proteinsSaïd El Kazzouli, Nancy E Lewin, Peter M Blumberg, et al.The Journal of Emergency Medicine|October 19, 2016
Does the Use of Ibuprofen in Children with Extremity Fractures Increase their Risk for Bone Healing Complications?Kerrin C DePeter, Stephen M Blumberg, Sarah Dienstag Becker, et al.Cancer Letters|August 1, 1987
Second stage tumor promoters: differences in biological potency and phorbol ester receptor affinity in C6 cellsK L Leach, M M Frost, P M Blumberg, et al.Pageof 79